SubscribeLogin
Published

Early valve replacement falls short in EVOLVED trial - Cardiovascular News

Summary by Cardiovascular News
Mark Dweck The question of early intervention among patients with severe aortic stenosis but no symptoms stood at the heart of two of the most significant trials presented at TCT 2024 (27–30 October, Washington, DC, USA). If EARLY TAVR prompted some to conclude that, instead of waiting for aortic stenosis symptoms to progress, physicians now have the evidence to justify an early intervention through transcatheter aortic valve implantation (TAVI)…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Washington DCWashington DC
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal